Panagora Asset Management’s Anika Therapeutics ANIK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | – | Sell |
-165
| Closed | -$7K | – | 1734 |
|
|
2021
Q2 | $7K | Buy |
165
+2
| +1% | +$85 | ﹤0.01% | 2361 |
|
|
2021
Q1 | $7K | Hold |
163
| – | – | ﹤0.01% | 2493 |
|
|
2020
Q4 | $7K | Buy |
+163
| New | +$7K | ﹤0.01% | 2369 |
|
|
2017
Q3 | – | Sell |
-1,315
| Closed | -$65K | – | 2313 |
|
|
2017
Q2 | $65K | Sell |
1,315
-1,933
| -60% | -$95.5K | ﹤0.01% | 2003 |
|
|
2017
Q1 | $141K | Sell |
3,248
-26,681
| -89% | -$1.16M | ﹤0.01% | 1764 |
|
|
2016
Q4 | $1.47M | Sell |
29,929
-436
| -1% | -$21.3K | 0.01% | 1038 |
|
|
2016
Q3 | $1.45M | Buy |
30,365
+1,513
| +5% | +$72.4K | 0.01% | 1046 |
|
|
2016
Q2 | $1.55M | Sell |
28,852
-1,382
| -5% | -$74.1K | 0.01% | 957 |
|
|
2016
Q1 | $1.35M | Buy |
30,234
+27,397
| +966% | +$1.23M | 0.01% | 990 |
|
|
2015
Q4 | $108K | Buy |
2,837
+1,522
| +116% | +$57.9K | ﹤0.01% | 1776 |
|
|
2015
Q3 | $42K | Sell |
1,315
-2,931
| -69% | -$93.6K | ﹤0.01% | 2034 |
|
|
2015
Q2 | $140K | Sell |
4,246
-11,412
| -73% | -$376K | ﹤0.01% | 1830 |
|
|
2015
Q1 | $645K | Buy |
15,658
+10,087
| +181% | +$416K | ﹤0.01% | 1221 |
|
|
2014
Q4 | $227K | Hold |
5,571
| – | – | ﹤0.01% | 1578 |
|
|
2014
Q3 | $204K | Sell |
5,571
-2,444
| -30% | -$89.5K | ﹤0.01% | 1624 |
|
|
2014
Q2 | $371K | Hold |
8,015
| – | – | ﹤0.01% | 1502 |
|
|
2014
Q1 | $329K | Hold |
8,015
| – | – | ﹤0.01% | 1574 |
|
|
2013
Q4 | $306K | Hold |
8,015
| – | – | ﹤0.01% | 1537 |
|
|
2013
Q3 | $192K | Hold |
8,015
| – | – | ﹤0.01% | 1678 |
|
|
2013
Q2 | $135K | Buy |
+8,015
| New | +$135K | ﹤0.01% | 1780 |
|